Maze Therapeutics President, R&D and CMO Harold Bernstein sells 16,141 common shares worth $425,392.65

Reuters2026/09/03 20:24

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Harold Bernstein, President, R&D & CMO, reported a same-day exercise and sale in Maze Therapeutics common stock on Sept. 1, 2026.
Exercised stock options for 16,141 shares at USD 10.42.
Sold 16,141 shares at an average USD 26.36, ending with zero shares owned directly.
Also acquired 20,000 shares via restricted stock units at no cost, ending with 20,000 shares held.
Derivative holdings reported at 160,662 stock options plus 20,000 restricted stock units following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002050172-26-000032), on September 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Maze Therapeutics President, R&D and CMO Harold Bernstein sells 16,141 common shares worth $425,392.65

You may also like

Crypto prices